½ÃÀ庸°í¼­
»óǰÄÚµå
1423705

½ÄÀ̺¸ÃæÁ¦ ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç° À¯Çü, ÇüÅÂ, À¯Åë ä³Î, ¿ëµµº°, Áö¿ªº° ¼¼°è ºÐ¼®

Dietary Supplements Market Forecasts to 2030 - Global Analysis By Product Type (Prebiotics & Probiotics, Proteins and Amino Acids, Herbal Supplements and Other Product Types), Form, Distribution Channel, Application and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ½ÄÀ̺¸ÃæÁ¦ ½ÃÀåÀº 2023³â¿¡ 1,820¾ï 4,000¸¸ ´Þ·¯¸¦ Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ Áß CAGR 11.0%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 3,779¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

½ÄÀ̺¸ÃæÁ¦ ½ÃÀåÀº ºñŸ¹Î, ¹Ì³×¶ö, Çãºê, ¾Æ¹Ì³ë»ê ¶Ç´Â ½Ä´ÜÀ» º¸ÃæÇϰí Àü¹ÝÀûÀÎ °Ç°­°ú À£ºù¿¡ ±â¿©ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ´Â ±âŸ ¹°ÁúÀ» ÇÔÀ¯ÇÑ Á¦Ç°À» »ý»ê ¹× ÆÇ¸ÅÇÏ´Â »ê¾÷À» ¸»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ º¸ÃæÁ¦´Â Á¤Á¦, ĸ½¶, ºÐ¸», ¾×ü µî ´Ù¾çÇÑ ÇüÅ·ΠÁ¦°øµÇ¸ç, ¿µ¾ç °áÇÌÀ» ÇØ°áÇϰųª ƯÁ¤ °Ç°­ ¸ñÇ¥¸¦ Áö¿øÇϰųª Àü¹ÝÀûÀÎ °Ç°­À» ÁõÁøÇϵµ·Ï ¼³°èµÇ¾î ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÄÀ̺¸ÃæÁ¦´Â »À °Ç°­ ÁõÁø, ¸é¿ª ±â´É Áö¿ø, ³ëÈ­ ¹× ¾î¸°ÀÌ ¹× ³ëÀΰú °°Àº ƯÁ¤ °èÃþÀÇ ¿ì·Á¿¡ ´ëÀÀÇÏ´Â µî Àü¹® ºÐ¾ß¿¡¼­µµ ¿ªÇÒÀ» ¼öÇàÇÕ´Ï´Ù.

±¹¸³º¸°Ç¿¬±¸¿ø¿¡ µû¸£¸é 2019³â °Ç°­º¸Á¶½Äǰ ÆÇ¸Å·®ÀÌ 38% Áõ°¡Çß´Ù°í ÇÕ´Ï´Ù. °Ç°­ º¸Á¶ ½ÄǰÀº ¹Ì·® ¿µ¾ç¼Ò °áÇÌÀ» °³¼±Çϰųª ÃæºÐÇÑ ¼·Ãë·®À» À¯ÁöÇÏ´Â µ¥ »ç¿ëÇÒ ¼ö ÀÖÀ¸¹Ç·Î °Ç°­ÇÑ »ç¶÷µéÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

³ô¾ÆÁö´Â °Ç°­ ÀǽÄ

°Ç°­À» À¯ÁöÇÏ´Â µ¥ ÀÖÀ¸¸ç, ¿µ¾çÀÇ ¿ªÇÒ¿¡ ´ëÇÑ °³ÀÎÀÇ Áö½ÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿¹¹æÀû °Ç°­°ü¸®ÀÇ Á߿伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚµéÀº ½ÄÀ̺¸ÃæÁ¦¸¦ ÅëÇØ °Ç°­À» ÁõÁøÇϰí ÀáÀçÀûÀÎ ¿µ¾ç °áÇÌÀ» ÇØ°áÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ» Àû±ØÀûÀ¸·Î ¸ð»öÇϰí ÀÖ½À´Ï´Ù. ¿µ¾ç°ú ¶óÀÌÇÁ½ºÅ¸ÀÏÀ» Æ÷°ýÇÏ´Â Á¾ÇÕÀûÀÎ °Ç°­ Á¢±Ù¹ý¿¡ ´ëÇÑ ¿­¸ÁÀº Çʼö ºñŸ¹Î, ¹Ì³×¶ö ¹× ±âŸ À¯ÀÍÇÑ È­ÇÕ¹°À» ÇÔÀ¯ÇÑ º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ÀνÄÀº ½ºÆ÷Ã÷ ½ÄÀ̺¸ÃæÁ¦¸¦ ã´Â ÀþÀº ÃþºÎÅÍ ³ëÈ­¿¡ µû¸¥ ƯÁ¤ °Ç°­ ¹®Á¦¸¦ Áö¿øÇϰíÀÚ ÇÏ´Â ³ë³âÃþ¿¡ À̸£±â±îÁö ´Ù¾çÇÑ °èÃþÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù.

Ç¥ÁØÈ­ ºÎÁ·

°Ç°­º¸Á¶½Äǰ¿¡ µû¶ó ¿ë¹ý, ¿ë·®, ¹èÇÕ, ǰÁú ±âÁØÀÌ Á¦°¢°¢ÀÎ °ÍÀº ¼ÒºñÀÚ¿Í ÀÇ·á Àü¹®°¡ ¸ðµÎ¿¡°Ô È¥¶õÀ» ¾ß±âÇÒ ¼ö ÀÖ½À´Ï´Ù. ÅëÀÏµÈ °¡À̵å¶óÀÎÀÌ ¾øÀ¸¸é Á¦Ç°ÀÇ Ç°Áú°ú È¿´É¿¡ Â÷À̰¡ ¹ß»ýÇÒ À§ÇèÀÌ ÀÖÀ¸¸ç, º¸ÃæÁ¦ ¼·Ãë¿¡ ´ëÇÑ Ç¥ÁØÈ­µÈ Á¢±Ù ¹æ½ÄÀ» È®¸³ÇÏ±â ¾î·Æ½À´Ï´Ù. ¸íÈ®ÇÑ ¼·Ãë ±ÇÀå·®ÀÌ ¾ø±â ¶§¹®¿¡ ºÎÀûÀýÇÑ »ç¿ëÀ¸·Î ÀÎÇØ ºÎÀÛ¿ëÀÌ ¹ß»ýÇϰųª º¸ÃæÁ¦ÀÇ È¿´ÉÀÌ ¶³¾îÁú ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª Ç¥ÁØÈ­ÀÇ ºÎÁ·Àº Á¾ÇÕÀûÀÎ ¿¬±¸¿Í ÀÓ»ó½ÃÇèÀ» ¼öÇàÇÏ´Â ´É·ÂÀ» ¹æÇØÇÏ°í ´Ù¾çÇÑ º¸ÃæÁ¦ÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀ» Áö¿øÇÏ´Â È®½ÇÇÑ °úÇÐÀû Áõ°Å¸¦ ÃàÀûÇÏ´Â µ¥ ¹æÇذ¡ µÇ°í ÀÖ½À´Ï´Ù.

Á¦Ç° Á¦ÇüÀÇ Çõ½Å

¾÷°èÀÇ ²÷ÀÓ¾ø´Â ¿¬±¸°³¹ß ³ë·ÂÀº È¿´É, »ýü ÀÌ¿ë·ü, ¼ÒºñÀÚ ¼±È£µµ¸¦ Çâ»ó½ÃŰ´Â »õ·Î¿î ÷´Ü Á¦Á¦ ¹× º¸ÃæÁ¦ °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½Å¿¡´Â Á¾Á¾ »õ·Î¿î ¼ººÐÀÇ ¹èÇÕ, Àü´Þ ¹æ¹ýÀÇ °³¼±, ƯÁ¤ °Ç°­ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ Ç¥Àû ¼Ö·ç¼ÇÀÇ °³¹ß µîÀÌ Æ÷ÇԵ˴ϴÙ. ¿¹¸¦ µé¾î ĸ½¶È­ ±â¼úÀÇ ¹ßÀü°ú »õ·Î¿î »ý¸®È°¼º È­ÇÕ¹°ÀÇ »ç¿ëÀº ¿µ¾ç Èí¼ö¸¦ ÃÖÀûÈ­ÇÑ º¸ÃæÁ¦ °³¹ß¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

À±¸®Àû ¹× ȯ°æÀû ¹®Á¦

½Ä¹° ¼ººÐÀÇ ³²È¹, Àǽɽº·¯¿î ³ëµ¿ °üÇà, ƯÁ¤ Á¶´Þ ¹æ½Ä¿¡ µû¸¥ ȯ°æ ¾ÇÈ­ µîÀÇ ¹®Á¦´Â À±¸®Àû ¹®Á¦¸¦ Á¦±âÇÕ´Ï´Ù. ¼ÒºñÀÚµéÀº Æ÷Àå Æó±â¹°°ú ÀÌ»êȭź¼Ò ¹èÃâ·® µî º¸ÃæÁ¦ Á¦Á¶°¡ ȯ°æ¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇØ ´õ Å« °ü½ÉÀ» °®°í ÀÖ½À´Ï´Ù. Ã¥ÀÓ°¨ ÀÖ°Ô Á¶´ÞµÈ ģȯ°æ º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ö¿ä´Â ¾÷°è°¡ °ø±Þ¸Á Àü¹Ý¿¡ °ÉÃÄ Áö¼Ó°¡´ÉÇÑ °üÇàÀ» äÅÃÇϵµ·Ï ¿ä±¸Çϰí ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ :

°ø±Þ¸Á, Á¦Á¶ ¹× À¯Åë ä³ÎÀÇ È¥¶õÀº ¾÷°è¿¡ µµÀüÀÌ µÇ°í ÀÖ½À´Ï´Ù. ºÀ¼â, °æÁ¦ ºÒÈ®½Ç¼º, ¼ÒºñÀÚ ¼Òºñ ÆÐÅÏÀÇ º¯È­´Â °³ÀÎÀÇ ±¸¸Å Çൿ¿¡ ¿µÇâÀ» ¹ÌÄ¡°í Àüü ½ÃÀå ¿ªÇп¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ À̹ø ÆÒµ¥¹ÍÀº °Ç°­±â´É½ÄǰÀÇ °¡¿ë¼º°ú ¾ÈÀü¼ºÀ» º¸ÀåÇÏ´Â µ¥ ÀÖÀ¸¸ç, ź·ÂÀûÀ̰í Åõ¸íÇÑ °ø±Þ¸ÁÀÇ Á߿伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. Àå±âÀûÀÎ ¿µÇâÀ¸·Î´Â °Ç°­ ¹× À£ºù¿¡ ´ëÇÑ °­Á¶°¡ °Ç°­±â´É½Äǰ ½ÃÀåÀÇ ÀûÀÀ·Â°ú Çõ½ÅÀÇ Çʿ伺°ú ÇÔ²² °Ç°­ ¹× À£ºù¿¡ ´ëÇÑ °­Á¶°¡ Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¿¹Ãø ±â°£ Áß ¾î¸°ÀÌ¿ë º¸ÃæÁ¦ ºÐ¾ß°¡ °¡Àå Ŭ °ÍÀ¸·Î ¿¹»ó

¾ÆÀ̵éÀÇ Àü¹ÝÀûÀÎ °Ç°­À» À§ÇØ ¿µ¾çÀÌ Áß¿äÇÏ´Ù´Â ºÎ¸ðµéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¾î¸°ÀÌ¿ë º¸ÃæÁ¦ ½ÃÀåÀº ¿¹Ãø ±â°£ Áß °¡Àå Å« ±Ô¸ð¸¦ Çü¼ºÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÚ³àÀÇ °Ç°­°ú ¹ß´Þ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó Àڳడ ÇÊ¿äÇÑ ºñŸ¹Î°ú ¹Ì³×¶öÀ» ¼·ÃëÇÒ ¼ö ÀÖµµ·Ï ½ÄÀ̺¸ÃæÁ¦¸¦ ÀÌ¿ëÇÏ´Â ºÎ¸ðµéÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±¸¹ÌÁ©¸®, Ãò¾îºí Á¤Á¦¿Í °°Àº Çõ½ÅÀûÀÌ°í ¸Å·ÂÀûÀÎ Á¦ÇüÀÌ ±ÞÁõÇϸ鼭 ¾î¸°À̵éÀÌ º¸ÃæÁ¦¸¦ ´õ ½±°Ô ¼·ÃëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ¼Ò¾Æ°ú ÀÇ»ç¿Í ÀÇ·á Àü¹®°¡µéÀº ¾ÆÀ̵éÀÇ ½Ä»ýȰ¿¡¼­ ¿µ¾ç ºÎÁ·À» ÇØ°áÇϱâ À§ÇØ ½ÄÀ̺¸ÃæÁ¦ »ç¿ëÀ» Àû±ØÀûÀ¸·Î ÁöÁöÇϰí ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÐ¾ß´Â ½ÉÀå °Ç°­ ºÐ¾ßÀÔ´Ï´Ù.

½ÉÀå °Ç°­ ºÐ¾ß´Â ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ç°­ÇÑ ½ÉÀåÀ» À¯ÁöÇÏ´Â µ¥ ÀÖÀ¸¸ç, ¿µ¾çÀÇ ¿ªÇÒ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¿À¸Þ°¡ 3 Áö¹æ»ê, ÄÚ¿£ÀÚÀÓQ10, ½Ä¹°¼º ½ºÅ×·Ñ µî ½ÉÇ÷°ü¿¡ ÁÁÀº °ÍÀ¸·Î ¾Ë·ÁÁø ¼ººÐÀ» ÇÔÀ¯ÇÑ °Ç°­±â´É½Äǰ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÂ½Ä »ýȰ°ú ½Ä½À°üÀÇ º¯È­·Î ÀÎÇØ ½ÉÀå¿¡ ÁÁÀº »ýȰ½À°üÀ» º¸¿ÏÇÏ´Â °Ç°­±â´É½Äǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °¢ Á¦Á¶¾÷üµéÀº °Ç°­°ü¸® Àü¹®°¡µéÀÇ ÁöÁö¸¦ ¹Þ¾Æ ½ÉÇ÷°ü °Ç°­ ÁõÁøÀ» ¸ñÇ¥·Î Çϴ Ư¼öÇÑ Á¦Á¦¸¦ Ãâ½ÃÇÏ¸ç ´ëÀÀÇϰí ÀÖ½À´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

ÃßÁ¤ ±â°£ Áß ¾Æ½Ã¾ÆÅÂÆò¾çÀº ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±Þ¼ÓÇÑ µµ½ÃÈ­, ¶óÀÌÇÁ½ºÅ¸ÀÏ º¯È­, ¿¹¹æ ÇコÄɾ ´ëÇÑ °ü½É Áõ°¡·Î ÀÎÇØ °Ç°­ º¸Á¶ ½ÄǰÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. °¡Ã³ºÐ ¼Òµæ Áõ°¡·Î Áß»êÃþÀÌ Áõ°¡ÇÏ¿© °Ç°­ º¸Á¶ ½ÄǰÀ» Æ÷ÇÔÇÑ °Ç°­ ¹× À£ºù Á¦Ç°¿¡ ´ëÇÑ ÅõÀÚ°¡ °¡´ÉÇØÁ³½À´Ï´Ù. ¶ÇÇÑ ¾ÆÀ¯¸£º£´Ù¿Í Áß±¹ ÀüÅë ÀÇÇÐ µîÀÇ ÀüÅë °ü½ÀÀº ÀÌ Áö¿ª¿¡¼­ Çãºê¿Í õ¿¬ º¸ÃæÁ¦ÀÇ ¼ö¿ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ Áß À¯¸®ÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °¢±¹ Á¤ºÎÀÇ ±ÔÁ¦ ¸íȮȭ¿Í ¾ö°ÝÇÑ Ç°Áú ±âÁØ °­È­·Î ÀÎÇØ °Ç°­±â´É½ÄǰÀÇ ¾ÈÀü¼º°ú È¿´É¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ½Å·Ú°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ±ÔÁ¦±â°üÀº Á¦Ç° ¶óº§¸µ, Á¦Á¶ °üÇà, ¼ººÐ ¾ÈÀü¿¡ ´ëÇÑ ¸íÈ®ÇÑ °¡À̵å¶óÀÎÀ» ¸¶·ÃÇÏ¿© Á¦Ç°ÀÇ Ç°Áú°ú ÁøÀ§ ¿©ºÎ¿¡ ´ëÇÑ ¿ì·Á¸¦ ÇØ¼ÒÇϱâ À§ÇØ Àû±ØÀûÀ¸·Î ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¤ºÎ´Â °øÁß º¸°Ç°ú °Ç°­ À¯Áö¸¦ ¿ì¼±½ÃÇϱâ À§ÇØ °Ç°­ º¸Á¶ ½Äǰ »ê¾÷ÀÇ ¿¬±¸°³¹ß ±¸»óÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º :

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. :

  • ±â¾÷ °³¿ä
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3»ç)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(ÃÖ´ë 3»ç)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤Ä¡, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º È®Àο¡ µû¶ó ´Ù¸§)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¿ªÀû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç ¾îÇÁ·ÎÄ¡
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ¼Ò½º
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç° ºÐ¼®
  • ¾ÖÇø®ÄÉÀÌ¼Ç ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ½ÄÀ̺¸ÃæÁ¦ ½ÃÀå : Á¦Ç° À¯Çüº°

  • ÇÁ¸®¹ÙÀÌ¿Àƽ½º¿Í ÇÁ·Î¹ÙÀÌ¿Àƽ½º
  • ´Ü¹éÁú°ú ¾Æ¹Ì³ë»ê
  • Çãºê º¸ÃæÁ¦
  • ºñŸ¹Î°ú ¹Ì³×¶ö
  • ¹Ì¿ë°ú ¾ÈƼ¿¡ÀÌ¡ º¸ÃæÁ¦
  • ¼Ò¾Æ¿ë º¸ÃæÁ¦
  • ¿À¸Þ°¡ 3 Áö¹æ»ê
  • ½Ã´Ï¾î¿ë °Ç°­º¸Á¶Á¦
  • Ư¼ö º¸ÃæÁ¦
  • ½ºÆ÷Ã÷ ¿µ¾çÇÐ
  • üÁß °ü¸®
  • ±âŸ Á¦Ç° À¯Çü

Á¦6Àå ¼¼°èÀÇ ½ÄÀ̺¸ÃæÁ¦ ½ÃÀå : Çüź°

  • ¾×ü
  • ¼ÒÇÁÆ®Á©
  • ±¸¹Ì
  • ºÐ¸»
  • ±âŸ Çü½Ä

Á¦7Àå ¼¼°èÀÇ ½ÄÀ̺¸ÃæÁ¦ ½ÃÀå : À¯Åë ä³Îº°

  • ¿Â¶óÀÎ ¼Ò¸Å ä³Î
  • ½´ÆÛ¸¶ÄÏ/ÇÏÀÌÆÛ¸¶ÄÏ
  • ¾à±¹¡¤µå·¯±×½ºÅä¾î

Á¦8Àå ¼¼°èÀÇ ½ÄÀ̺¸ÃæÁ¦ ½ÃÀå : ¿ëµµº°

  • ÇǺÎ/Çì¾î/³×ÀÏ
  • ´ç´¢º´
  • ½ÉÀå °Ç°­
  • À§Àå °Ç°­
  • ¿¡³ÊÁö¿Í üÁß °ü¸®
  • »À¿Í °üÀý °Ç°­
  • ÀÏ¹Ý °Ç°­
  • ±âŸ ¿ëµµ

Á¦9Àå ¼¼°èÀÇ ½ÄÀ̺¸ÃæÁ¦ ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕº´»ç¾÷
  • ÀμöÇÕº´
  • ½ÅÁ¦Ç°ÀÇ ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦11Àå ±â¾÷ °³¿ä

  • Bayer AG
  • Amway Corporation
  • Herbalife Nutrition
  • Pfizer Inc
  • Abbott Laboratories
  • Haleon Plc
  • Suntory Holdings Ltd
  • Otsuka Holdings Co. Ltd
  • Glanbia PLC
  • The Bountiful Company
  • Bionova Lifesciences
  • Carlyle Group
  • Arkopharma Laboratoires Pharmaceutiques
KSA 24.02.21

According to Stratistics MRC, the Global Dietary Supplements Market is accounted for $182.04 billion in 2023 and is expected to reach $377.94 billion by 2030 growing at a CAGR of 11.0% during the forecast period. The dietary supplements market refers to the industry that produces and markets products containing vitamins, minerals, herbs, amino acids, or other substances intended to supplement the diet and contribute to overall health and well-being. These supplements come in various forms, such as pills, capsules, powders, and liquids, and are designed to address nutritional deficiencies, support specific health goals, or enhance overall wellness. Additionally, dietary supplements play a role in specialized areas such as promoting bone health, supporting immune function, and addressing concerns related to aging or specific demographic groups like children or seniors.

According to the National Institute of Health, the sales of dietary supplements increased at a rate of 38% in 2019. Growing numbers of healthy people are taking dietary supplements as they can be used to correct micronutrient deficiency or maintain an adequate intake.

Market Dynamics:

Driver:

Growing health awareness

As individuals become more informed about the role of nutrition in maintaining overall health, there is a heightened emphasis on preventive healthcare practices. Consumers are proactively seeking ways to enhance their well-being and address potential nutritional deficiencies through the use of dietary supplements. The desire for a holistic approach to health, encompassing nutrition and lifestyle, has fueled the demand for supplements containing essential vitamins, minerals, and other beneficial compounds. Moreover, this awareness extends to various demographic groups, from young adults seeking sports nutrition supplements to seniors aiming to support specific health concerns associated with aging.

Restraint:

Lack of standardization

Variability in dosages, formulations, and quality standards across different supplements can create confusion for consumers and healthcare professionals alike. Without uniform guidelines, there is a risk of inconsistent product quality and efficacy, making it challenging to establish a standardized approach to supplement consumption. The absence of clear dosing recommendations can lead to improper use, potentially causing adverse effects or diminishing the perceived effectiveness of supplements. However, the lack of standardization hampers the ability to conduct comprehensive research and clinical trials, hindering the accumulation of robust scientific evidence supporting the efficacy and safety of various supplements.

Opportunity:

Innovations in product formulations

Continuous research and development efforts within the industry lead to novel and advanced formulations, fostering the creation of supplements with improved efficacy, bioavailability, and consumer appeal. These innovations often involve the incorporation of new ingredients, enhanced delivery methods, and the development of targeted solutions to address specific health concerns. For instance, advancements in encapsulation technologies and the utilization of novel bioactive compounds contribute to the creation of supplements with optimized nutrient absorption.

Threat:

Ethical and environmental concerns

Issues such as overharvesting of botanical ingredients, questionable labor practices, and environmental degradation associated with certain sourcing methods raise ethical considerations. Consumers are becoming more conscious of the environmental impact of supplement production, including packaging waste and carbon footprints. The demand for responsibly sourced and eco-friendly supplements challenges the industry to adopt sustainable practices throughout the supply chain.

Covid-19 Impact:

Disruptions in the supply chain, manufacturing, and distribution channels have posed challenges for the industry. Lockdowns, economic uncertainties, and shifts in consumer spending patterns have influenced the purchasing behavior of individuals, impacting overall market dynamics. Additionally, the pandemic has highlighted the importance of a resilient and transparent supply chain in ensuring the availability and safety of dietary supplements. The long-term impact will likely involve an increased emphasis on health and wellness, coupled with a need for adaptability and innovation within the dietary supplements market.

The children's supplements segment is expected to be the largest during the forecast period

Children's supplements segment is expected to be the largest during the forecast period due to growing awareness among parents about the importance of nutrition for their children's overall well-being. As concerns about children's health and development rise, parents are increasingly turning to dietary supplements to ensure their kids receive essential vitamins and minerals. The market has responded with a surge in innovative and appealing formulations, such as gummies and chewable tablets, making it easier for children to consume these supplements. Additionally, pediatricians and healthcare professionals are actively endorsing the use of dietary supplements to address nutritional gaps in children's diets.

The cardiac health segment is expected to have the highest CAGR during the forecast period

Cardiac health segment is expected to have the highest CAGR during the forecast period. With rising awareness about the role of nutrition in maintaining a healthy heart, individuals are turning to dietary supplements containing ingredients like omega-3 fatty acids, Coenzyme Q10, and plant sterols known for their cardiovascular benefits. Moreover, a sedentary lifestyle and poor dietary habits have spurred the demand for supplements that can complement heart-healthy lifestyles. Moreover, manufacturers are responding by introducing specialized formulations targeted at promoting cardiovascular well-being, endorsed by healthcare professionals.

Region with largest share:

Asia Pacific region commanded the largest share of the market throughout the extrapolated period. Rapid urbanization, changing lifestyles, and an increasing focus on preventive healthcare have led to a heightened awareness of the importance of nutritional supplementation. Growing disposable incomes have enabled a rising middle class to invest in health and wellness products, including dietary supplements. Moreover, traditional practices such as Ayurveda and Traditional Chinese Medicine have contributed to the acceptance of herbal and natural supplements in the region.

Region with highest CAGR:

Asia Pacific region is estimated to witness lucrative growth over the projected period. Increased regulatory clarity and stringent quality standards enforced by governments across the region have bolstered consumer confidence in the safety and efficacy of dietary supplements. Regulatory bodies are actively working to establish clear guidelines for product labeling, manufacturing practices, and ingredient safety, addressing concerns related to product quality and authenticity. Furthermore, as governments prioritize public health and wellness, they are also supporting research and development initiatives in the dietary supplements industry.

Key players in the market

Some of the key players in Dietary Supplements market include Bayer AG, Amway Corporation, Herbalife Nutrition, Pfizer Inc, Abbott Laboratories, Haleon Plc, Suntory Holdings Ltd, Otsuka Holdings Co. Ltd, Glanbia PLC, The Bountiful Company, Bionova Lifesciences, Carlyle Group and Arkopharma Laboratoires Pharmaceutiques.

Key Developments:

In September 2022, Abbott launched a brand-new Ensure formulation with HMB. As a science-based nutritional supplement, the new Ensure contains 32 essential nutrients such as protein, calcium, and vitamin D to help improve muscle and bone strength. It contains HMB or hydroxy-methyl butyrate, a new ingredient that helps counteract muscle loss and increases the strength and power of the body.

In August 2022, Optimum Nutrition, a Glanbia Performance Nutrition brand, launched its brand-new Gold Standard Protein Shake. The new drink has two flavors: chocolate and vanilla. Each serving contains 24 grams of protein.

In March 2022, PharmaNutrics launched five different dietary supplements in the United States. SerotomixPlus, GlucanPlus, Gaba 600, EnergixPlux, and CurcumixPlux serve different purposes for fatigue, stress, musculoskeleton, and anti-inflammatory support.

Product Types Covered:

  • Prebiotics & Probiotics
  • Proteins and Amino Acids
  • Herbal Supplements
  • Vitamins & Minerals
  • Beauty and Anti-Aging Supplements
  • Children's Supplements
  • Omega-3 Fatty Acids
  • Senior Health Supplements
  • Specialty Supplements
  • Sports Nutrition
  • Weight Management
  • Other Product Types

Forms Covered:

  • Liquids
  • Softgels
  • Gummies
  • Powders
  • Other Forms

Distribution Channels Covered:

  • Online Retail Channels
  • Supermarkets/Hypermarkets
  • Pharmacies and Drug Stores

Applications Covered:

  • Skin/Hair/Nails
  • Diabetes
  • Cardiac Health
  • Gastrointestinal Health
  • Energy & Weight Management
  • Bone & Joint Health
  • General Health
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Dietary Supplements Market, By Product Type

  • 5.1 Introduction
  • 5.2 Prebiotics & Probiotics
  • 5.3 Proteins and Amino Acids
  • 5.4 Herbal Supplements
  • 5.5 Vitamins & Minerals
  • 5.6 Beauty and Anti-Aging Supplements
  • 5.7 Children's Supplements
  • 5.8 Omega-3 Fatty Acids
  • 5.9 Senior Health Supplements
  • 5.10 Specialty Supplements
  • 5.11 Sports Nutrition
  • 5.12 Weight Management
  • 5.13 Other Product Types

6 Global Dietary Supplements Market, By Form

  • 6.1 Introduction
  • 6.2 Liquids
  • 6.3 Softgels
  • 6.4 Gummies
  • 6.5 Powders
  • 6.6 Other Forms

7 Global Dietary Supplements Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Online Retail Channels
  • 7.3 Supermarkets/Hypermarkets
  • 7.4 Pharmacies and Drug Stores

8 Global Dietary Supplements Market, By Application

  • 8.1 Introduction
  • 8.2 Skin/Hair/Nails
  • 8.3 Diabetes
  • 8.4 Cardiac Health
  • 8.5 Gastrointestinal Health
  • 8.6 Energy & Weight Management
  • 8.7 Bone & Joint Health
  • 8.8 General Health
  • 8.9 Other Applications

9 Global Dietary Supplements Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Bayer AG
  • 11.2 Amway Corporation
  • 11.3 Herbalife Nutrition
  • 11.4 Pfizer Inc
  • 11.5 Abbott Laboratories
  • 11.6 Haleon Plc
  • 11.7 Suntory Holdings Ltd
  • 11.8 Otsuka Holdings Co. Ltd
  • 11.9 Glanbia PLC
  • 11.10 The Bountiful Company
  • 11.11 Bionova Lifesciences
  • 11.12 Carlyle Group
  • 11.13 Arkopharma Laboratoires Pharmaceutiques
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦